25 XP   0   0   10

PDS Biotechnology Corp
Buy, Hold or Sell?

Let's analyse PDS Biotechnology Corp together

PenkeI guess you are interested in PDS Biotechnology Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PDS Biotechnology Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PDS Biotechnology Corp

I send you an email if I find something interesting about PDS Biotechnology Corp.

Quick analysis of PDS Biotechnology Corp (30 sec.)










What can you expect buying and holding a share of PDS Biotechnology Corp? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.67
Expected worth in 1 year
€-1.16
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
€-1.83
Return On Investment
-68.6%

For what price can you sell your share?

Current Price per Share
€2.67
Expected price per share
€0 - €4.84
How sure are you?
50%

1. Valuation of PDS Biotechnology Corp (5 min.)




Live pricePrice per Share (EOD)

€2.67

Intrinsic Value Per Share

€-10.98 - €-4.61

Total Value Per Share

€-10.31 - €-3.94

2. Growth of PDS Biotechnology Corp (5 min.)




Is PDS Biotechnology Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$26.1m$44m-$17.8m-68.4%

How much money is PDS Biotechnology Corp making?

Current yearPrevious yearGrowGrow %
Making money-$42.9m-$40.8m-$2m-4.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of PDS Biotechnology Corp (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#551 / 1016

Most Revenue
#951 / 1016

Most Profit
#573 / 1016

Most Efficient
#397 / 1016

What can you expect buying and holding a share of PDS Biotechnology Corp? (5 min.)

Welcome investor! PDS Biotechnology Corp's management wants to use your money to grow the business. In return you get a share of PDS Biotechnology Corp.

What can you expect buying and holding a share of PDS Biotechnology Corp?

First you should know what it really means to hold a share of PDS Biotechnology Corp. And how you can make/lose money.

Speculation

The Price per Share of PDS Biotechnology Corp is €2.668. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of PDS Biotechnology Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in PDS Biotechnology Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.67. Based on the TTM, the Book Value Change Per Share is €-0.46 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of PDS Biotechnology Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-1.17-43.9%-1.17-43.9%-1.11-41.7%-0.67-25.0%-0.46-17.2%
Usd Book Value Change Per Share-0.49-18.3%-0.49-18.3%-0.52-19.6%-0.02-0.8%0.093.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.49-18.3%-0.49-18.3%-0.52-19.6%-0.02-0.8%0.093.3%
Usd Price Per Share4.86-4.86-12.72-5.90-6.32-
Price to Earnings Ratio-4.15--4.15--11.42--10.11--30.52-
Price-to-Total Gains Ratio-9.97--9.97--24.28--5.63--4.33-
Price to Book Ratio6.82-6.82-10.60-6.57-5.39-
Price-to-Total Gains Ratio-9.97--9.97--24.28--5.63--4.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.8403528
Number of shares352
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.49-0.02
Usd Total Gains Per Share-0.49-0.02
Gains per Quarter (352 shares)-171.50-7.12
Gains per Year (352 shares)-686.00-28.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-686-6960-28-38
20-1372-13820-57-66
30-2058-20680-85-94
40-2744-27540-114-122
50-3430-34400-142-150
60-4116-41260-171-178
70-4802-48120-199-206
80-5488-54980-228-234
90-6174-61840-256-262
100-6860-68700-285-290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.05.00.037.5%3.05.00.037.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.05.00.037.5%3.05.00.037.5%

Fundamentals of PDS Biotechnology Corp

About PDS Biotechnology Corp

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein (TARP) for treating prostate and breast cancers; and PDS0103 for ovarian, colorectal, lung, and breast cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment; and PDS0104, a novel investigational Tyrosinase-related Protein 2 targeted immunotherapy that stimulates a potent targeted T cell attack against melanoma. Further, the company provides PDS0202, a novel investigational influenza vaccine that generates broad and robust antibody and T cell responses that provide protection against continually evolving strains of seasonal flu and potentially emerging pandemic flu. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. The company was founded in 2005 and is based in Princeton, New Jersey.

Fundamental data was last updated by Penke on 2024-04-18 06:47:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of PDS Biotechnology Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit PDS Biotechnology Corp earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PDS Biotechnology Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y--438.4%+438.4%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient PDS Biotechnology Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • -72.3% Return on Assets means that PDS Biotechnology Corp generated €-0.72 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PDS Biotechnology Corp:

  • The MRQ is -72.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -72.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-72.3%TTM-72.3%0.0%
TTM-72.3%YOY-53.1%-19.3%
TTM-72.3%5Y-49.4%-22.9%
5Y-49.4%10Y-56.2%+6.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.3%-13.5%-58.8%
TTM-72.3%-12.9%-59.4%
YOY-53.1%-11.8%-41.3%
5Y-49.4%-14.1%-35.3%
10Y-56.2%-16.0%-40.2%
1.1.3. Return on Equity

Shows how efficient PDS Biotechnology Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • -164.3% Return on Equity means PDS Biotechnology Corp generated €-1.64 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PDS Biotechnology Corp:

  • The MRQ is -164.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -164.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-164.3%TTM-164.3%0.0%
TTM-164.3%YOY-92.8%-71.5%
TTM-164.3%5Y-79.7%-84.6%
5Y-79.7%10Y-82.6%+2.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-164.3%-16.9%-147.4%
TTM-164.3%-16.1%-148.2%
YOY-92.8%-15.1%-77.7%
5Y-79.7%-19.9%-59.8%
10Y-82.6%-20.9%-61.7%

1.2. Operating Efficiency of PDS Biotechnology Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient PDS Biotechnology Corp is operating .

  • Measures how much profit PDS Biotechnology Corp makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PDS Biotechnology Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--477.4%+477.4%
10Y--625.6%+625.6%
1.2.2. Operating Ratio

Measures how efficient PDS Biotechnology Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y-5.679-5.679
10Y-7.894-7.894

1.3. Liquidity of PDS Biotechnology Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if PDS Biotechnology Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.33 means the company has €4.33 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 4.333. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.333. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.333TTM4.3330.000
TTM4.333YOY7.787-3.455
TTM4.3335Y8.874-4.542
5Y8.87410Y5.957+2.917
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3333.914+0.419
TTM4.3334.220+0.113
YOY7.7875.388+2.399
5Y8.8746.045+2.829
10Y5.9576.406-0.449
1.3.2. Quick Ratio

Measures if PDS Biotechnology Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.003-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.572-3.572
TTM-3.998-3.998
YOY-5.390-5.390
5Y-5.969-5.969
10Y0.0036.287-6.284

1.4. Solvency of PDS Biotechnology Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of PDS Biotechnology Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare PDS Biotechnology Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.56 means that PDS Biotechnology Corp assets are financed with 56.0% credit (debt) and the remaining percentage (100% - 56.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.560. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.560. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.560TTM0.5600.000
TTM0.560YOY0.429+0.131
TTM0.5605Y0.272+0.288
5Y0.27210Y0.258+0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5600.336+0.224
TTM0.5600.334+0.226
YOY0.4290.269+0.160
5Y0.2720.366-0.094
10Y0.2580.390-0.132
1.4.2. Debt to Equity Ratio

Measures if PDS Biotechnology Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Debt to Equity ratio of 127.3% means that company has €1.27 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 1.273. The company is able to pay all its debts with equity. +1
  • The TTM is 1.273. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.273TTM1.2730.000
TTM1.273YOY0.750+0.523
TTM1.2735Y0.493+0.780
5Y0.49310Y0.426+0.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2730.382+0.891
TTM1.2730.396+0.877
YOY0.7500.335+0.415
5Y0.4930.434+0.059
10Y0.4260.465-0.039

2. Market Valuation of PDS Biotechnology Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings PDS Biotechnology Corp generates.

  • Above 15 is considered overpriced but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A PE ratio of -4.15 means the investor is paying €-4.15 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PDS Biotechnology Corp:

  • The EOD is -2.426. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.151. Based on the earnings, the company is expensive. -2
  • The TTM is -4.151. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.426MRQ-4.151+1.725
MRQ-4.151TTM-4.1510.000
TTM-4.151YOY-11.417+7.266
TTM-4.1515Y-10.113+5.962
5Y-10.11310Y-30.517+20.404
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.426-2.259-0.167
MRQ-4.151-2.569-1.582
TTM-4.151-2.664-1.487
YOY-11.417-4.120-7.297
5Y-10.113-6.258-3.855
10Y-30.517-6.171-24.346
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PDS Biotechnology Corp:

  • The EOD is -3.097. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.300. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.300. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.097MRQ-5.300+2.202
MRQ-5.300TTM-5.3000.000
TTM-5.300YOY-18.143+12.843
TTM-5.3005Y-11.143+5.843
5Y-11.14310Y-7.927-3.216
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.097-2.924-0.173
MRQ-5.300-3.246-2.054
TTM-5.300-3.488-1.812
YOY-18.143-5.620-12.523
5Y-11.143-8.315-2.828
10Y-7.927-8.826+0.899
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of PDS Biotechnology Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.82 means the investor is paying €6.82 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of PDS Biotechnology Corp:

  • The EOD is 3.987. Based on the equity, the company is fair priced.
  • The MRQ is 6.822. Based on the equity, the company is overpriced. -1
  • The TTM is 6.822. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.987MRQ6.822-2.835
MRQ6.822TTM6.8220.000
TTM6.822YOY10.601-3.779
TTM6.8225Y6.573+0.249
5Y6.57310Y5.392+1.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.9871.851+2.136
MRQ6.8222.090+4.732
TTM6.8222.095+4.727
YOY10.6012.844+7.757
5Y6.5733.466+3.107
10Y5.3923.815+1.577
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of PDS Biotechnology Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.458-0.4580%-0.492+7%-0.019-96%0.084-647%
Book Value Per Share--0.6690.6690%1.127-41%0.882-24%1.132-41%
Current Ratio--4.3334.3330%7.787-44%8.874-51%5.957-27%
Debt To Asset Ratio--0.5600.5600%0.429+31%0.272+106%0.258+117%
Debt To Equity Ratio--1.2731.2730%0.750+70%0.493+158%0.426+199%
Dividend Per Share----0%-0%-0%-0%
Eps---1.100-1.1000%-1.046-5%-0.628-43%-0.430-61%
Free Cash Flow Per Share---0.861-0.8610%-0.658-24%-0.528-39%-0.648-25%
Free Cash Flow To Equity Per Share---0.442-0.4420%0.220-301%0.139-419%-0.163-63%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.613--------
Intrinsic Value_10Y_min---10.977--------
Intrinsic Value_1Y_max---0.515--------
Intrinsic Value_1Y_min---0.743--------
Intrinsic Value_3Y_max---1.507--------
Intrinsic Value_3Y_min---2.556--------
Intrinsic Value_5Y_max---2.451--------
Intrinsic Value_5Y_min---4.707--------
Market Cap97860372.400-71%167441004.500167441004.5000%438134238.500-62%203379382.640-18%217650381.288-23%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio3.987-71%6.8226.8220%10.601-36%6.573+4%5.392+27%
Pe Ratio-2.426+42%-4.151-4.1510%-11.417+175%-10.113+144%-30.517+635%
Price Per Share2.668-71%4.5654.5650%11.945-62%5.545-18%5.934-23%
Price To Free Cash Flow Ratio-3.097+42%-5.300-5.3000%-18.143+242%-11.143+110%-7.927+50%
Price To Total Gains Ratio-5.830+42%-9.975-9.9750%-24.284+143%-5.630-44%-4.329-57%
Quick Ratio----0%-0%-0%0.003-100%
Return On Assets---0.723-0.7230%-0.531-27%-0.494-32%-0.562-22%
Return On Equity---1.643-1.6430%-0.928-44%-0.797-52%-0.826-50%
Total Gains Per Share---0.458-0.4580%-0.492+7%-0.019-96%0.084-647%
Usd Book Value--26130392.50126130392.5010%44001096.277-41%34433406.708-24%44206294.798-41%
Usd Book Value Change Per Share---0.487-0.4870%-0.524+7%-0.020-96%0.089-647%
Usd Book Value Per Share--0.7120.7120%1.200-41%0.939-24%1.205-41%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.171-1.1710%-1.114-5%-0.668-43%-0.458-61%
Usd Free Cash Flow---33635422.241-33635422.2410%-25709160.440-24%-20610465.037-39%-22136199.885-34%
Usd Free Cash Flow Per Share---0.917-0.9170%-0.701-24%-0.562-39%-0.690-25%
Usd Free Cash Flow To Equity Per Share---0.471-0.4710%0.234-301%0.148-419%-0.173-63%
Usd Market Cap104182152.457-71%178257693.391178257693.3910%466437710.307-62%216517690.759-18%231710595.919-23%
Usd Price Per Share2.840-71%4.8604.8600%12.717-62%5.903-18%6.317-23%
Usd Profit---42941286.767-42941286.7670%-40853988.060-5%-24511783.049-43%-31638119.000-26%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.487-0.4870%-0.524+7%-0.020-96%0.089-647%
 EOD+3 -5MRQTTM+0 -0YOY+7 -215Y+1 -2710Y+1 -28

3.2. Fundamental Score

Let's check the fundamental score of PDS Biotechnology Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.426
Price to Book Ratio (EOD)Between0-13.987
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than14.333
Debt to Asset Ratio (MRQ)Less than10.560
Debt to Equity Ratio (MRQ)Less than11.273
Return on Equity (MRQ)Greater than0.15-1.643
Return on Assets (MRQ)Greater than0.05-0.723
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of PDS Biotechnology Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.668
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets59,390
Total Liabilities33,259
Total Stockholder Equity26,131
 As reported
Total Liabilities 33,259
Total Stockholder Equity+ 26,131
Total Assets = 59,390

Assets

Total Assets59,390
Total Current Assets59,055
Long-term Assets335
Total Current Assets
Cash And Cash Equivalents 56,561
Other Current Assets 2,495
Total Current Assets  (as reported)59,055
Total Current Assets  (calculated)59,055
+/-0
Long-term Assets
Property Plant Equipment 335
Long-term Assets  (as reported)335
Long-term Assets  (calculated)335
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,630
Long-term Liabilities19,629
Total Stockholder Equity26,131
Total Current Liabilities
Short Long Term Debt 4,167
Accounts payable 6,983
Total Current Liabilities  (as reported)13,630
Total Current Liabilities  (calculated)11,149
+/- 2,480
Long-term Liabilities
Long term Debt 19,506
Capital Lease Obligations Min Short Term Debt179
Long-term Liabilities  (as reported)19,629
Long-term Liabilities  (calculated)19,685
+/- 56
Total Stockholder Equity
Total Stockholder Equity (as reported)26,131
Total Stockholder Equity (calculated)0
+/- 26,131
Other
Capital Stock11
Common Stock Shares Outstanding 33,095
Net Invested Capital 49,804
Net Working Capital 45,425
Property Plant and Equipment Gross 468



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
110,914
92,621
36,221
14,491
30,890
67,198
77,008
59,390
59,39077,00867,19830,89014,49136,22192,621110,914
   > Total Current Assets 
2,101
231
122
14,470
30,337
66,840
76,480
59,055
59,05576,48066,84030,33714,4701222312,101
       Cash And Cash Equivalents 
106,399
88,068
34,646
12,162
28,840
65,243
73,820
56,561
56,56173,82065,24328,84012,16234,64688,068106,399
       Net Receivables 
13
4
0
0
0
0
0
0
000000413
       Other Current Assets 
0
0
0
2,308
1,498
1,598
2,660
2,495
2,4952,6601,5981,4982,308000
   > Long-term Assets 
3,561
3,567
570
21
553
358
528
335
335528358553215703,5673,561
       Property Plant Equipment 
73
52
30
21
553
358
528
335
33552835855321305273
       Long-term Assets Other 
143
143
143
0
0
0
0
0
00000143143143
> Total Liabilities 
21,638
30,250
6,382
2,794
3,761
3,987
33,006
33,259
33,25933,0063,9873,7612,7946,38230,25021,638
   > Total Current Liabilities 
707
919
1,909
2,794
3,270
3,756
9,821
13,630
13,6309,8213,7563,2702,7941,909919707
       Short Long Term Debt 
0
3,075
0
0
0
0
0
4,167
4,167000003,0750
       Accounts payable 
397
624
1,308
1,198
1,415
1,309
1,219
6,983
6,9831,2191,3091,4151,1981,308624397
       Other Current Liabilities 
0
0
5,563
498
0
0
0
0
00004985,56300
   > Long-term Liabilities 
14,953
17,383
0
0
490
231
23,185
19,629
19,62923,1852314900017,38314,953
       Long term Debt 
14,953
17,383
0
0
0
0
23,021
19,506
19,50623,021000017,38314,953
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
610
490
452
179
1794524906100000
       Other Liabilities 
0
0
291
0
0
0
0
0
0000029100
> Total Stockholder Equity
89,277
62,371
29,839
11,698
27,130
63,210
44,002
26,131
26,13144,00263,21027,13011,69829,83962,37189,277
   Common Stock
0
0
1
2
7
9
10
0
010972100
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 00000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-43,045
Operating Income-43,045-43,045
 
Operating Expense (+$)
Research Development27,763
Selling General Administrative15,282
Selling And Marketing Expenses-
Operating Expense43,04543,045
 
Net Interest Income (+$)
Interest Income2,903
Interest Expense-4,206
Other Finance Cost-0
Net Interest Income-1,303
 
Pretax Income (+$)
Operating Income-43,045
Net Interest Income-1,303
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-44,348-43,045
EBIT - interestExpense = -4,206
-42,942
-38,736
Interest Expense4,206
Earnings Before Interest and Taxes (EBIT)--40,142
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-44,348
Tax Provision--1,406
Net Income From Continuing Ops-42,942-42,942
Net Income-42,942
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,303
 

Technical Analysis of PDS Biotechnology Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of PDS Biotechnology Corp. The general trend of PDS Biotechnology Corp is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine PDS Biotechnology Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PDS Biotechnology Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.695 < 4.58 < 4.84.

The bearish price targets are: .

Tweet this
PDS Biotechnology Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PDS Biotechnology Corp. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PDS Biotechnology Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Moving Average Convergence/Divergence (MACD) ChartPDS Biotechnology Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PDS Biotechnology Corp. The current adx is .

PDS Biotechnology Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Relative Strength Index (RSI) ChartPDS Biotechnology Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Stochastic Oscillator ChartPDS Biotechnology Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Commodity Channel Index (CCI) ChartPDS Biotechnology Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Chande Momentum Oscillator (CMO) ChartPDS Biotechnology Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Williams %R ChartPDS Biotechnology Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Average True Range (ATR) ChartPDS Biotechnology Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily On-Balance Volume (OBV) ChartPDS Biotechnology Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Money Flow Index (MFI) ChartPDS Biotechnology Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PDS Biotechnology Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

PDS Biotechnology Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PDS Biotechnology Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.668
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of PDS Biotechnology Corp with someone you think should read this too:
  • Are you bullish or bearish on PDS Biotechnology Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about PDS Biotechnology Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PDS Biotechnology Corp

I send you an email if I find something interesting about PDS Biotechnology Corp.


Comments

How you think about this?

Leave a comment

Stay informed about PDS Biotechnology Corp.

Receive notifications about PDS Biotechnology Corp in your mailbox!